Tiratricol FDA approval: targets and potency in BioQ
Tiratricol FDA approval (Emcitate): ChEMBL shows 68 targets, THRB and THRA top by pChEMBL, and 3 registered trials on ClinicalTrials.gov, as of 2026-11-17.
BioQ Blog
Every BioQ post about ChEMBL: real search results, sources and the query to repeat it.
Tiratricol FDA approval (Emcitate): ChEMBL shows 68 targets, THRB and THRA top by pChEMBL, and 3 registered trials on ClinicalTrials.gov, as of 2026-11-17.
NCT07877584 is a phase 3 NSCLC trial of PD-1 blockade with or without chemotherapy; BioQ adds carboplatin ChEMBL potency and ClinicalTrials.gov context.
A new FAERS paper on semaglutide and panic attacks, set against ChEMBL potency, ClinicalTrials.gov registrations and PubChem identity as of 2026-11-15.
NCT06966843 tests dantrolene in statin-induced myopathy; BioQ pulls its ChEMBL potency and 7 registered dantrolene trials, data as of 2026-11-11.
NCT07879612 tests semaglutide in Cannabis Use Disorder; BioQ pulls GLP1R potency from ChEMBL and 349 semaglutide trials from ClinicalTrials.gov.
Script a gene-to-drug lookup with the BioQ REST API: one call for TP53 returns 18 drugs with stage and pChEMBL potency, data as of 2026-11-06.
One query, EGFR gefitinib, returns IC50 binding measurements, trial counts and CIViC evidence for the pair from three resources, as of 2026-11-06.